Biotechnology - Pullman, Washington, United States
Chimeric Designs aims to utilize the highly potent biopharmaceutical drug delivery vehicle, antibody drug conjugates (ADCs) for targeted delivery of chemotherapy agents. An antibody is a protein targeted at cancerous cells. Unlike traditional chemotherapy, ADCs are designed to deliver an attached drug payload directly to the cancerous cells, thereby sparing healthy tissue.We are developing the world's first multifunctional ADC, to make chemotherapy more efficient.